ELAVL1 and metabolic dysfunction-associated steatotic liver disease: The rationale for this narrative review is based on HuR’s emerging role as a critical post-transcriptional regulator of metabolic homeostasis, inflammation, and fibrosis—the hallmark features of MASLD and its progression to MASH.